RXO RXO reports wider than expected Q4 2025 per share loss shares rise 466 percent today VRAX Virax outlines new infectious disease testing rollout plans to drive upcoming fiscal year growth Vanguard SmallCap Index Admiral VB Neutral 2026 Assessment of Performance Risk and Cost Profile BXC Bluelinx reports wider than expected Q4 2025 loss shares fall 66 percent in todays trading Nonprofit Financial Distress Signals Undercapitalization Not Organizational Failure Grupo SIM Stock Consolidating at 3002 Next Move Ahead 20260518 Primis Financial Director Robert Clagett Invests Nearly 20000 in Company Stock